Biomarkers of Tumor Progression, Prognosis and Therapy 2.0

Dear Colleagues,

Though cancer development and progression involve the aberrations of complex cellular pathways at the genetic and epigenetic levels, detection of a set of selected biomarkers may have prognostic relevance and/or may offer targets for tumor therapy. These biomarkers can be either directly related to cancer evolution, such as tumor driver/oncogenes and their protein products, or can reflect e.g., protective responses of cancer to hypoxia or the body’s defense mechanisms against carcinogenesis, or reveal impaired cell-death mechanisms. Biomarkers can be discovered at different levels including DNA, the transcribed mRNA, and its epigenetic regulators, miRNAs, as well as the translated proteins which may deregulate essential cell functions and lead to cancer and its aggressive progression. Besides functional testing, advanced molecular methods can be used and combined for identifying cancer biomarkers including next generation sequencing (NGS), in situ hybridization, immunological methods, and proteomics. Research data can be supported by the in silico analysis of biomarker databases and machine-learning- and artificial-intelligence-based automated image analysis of in situ-detected molecules.

This Special Issue “Biomarkers of Tumor Progression, Prognosis and Therapy 2.0” of the International Journal of Molecular Sciences aims to introduce novel biomarkers and review established ones which may have important impacts on tumor fate by using and combining up-to-date in silico, in vitro, and in situ molecular methods in a range of cancer types.

Prof. Dr. Tibor Krenacs
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cancer biomarkers
• genetic aberrations
• carcinogenesis
• cancer progression
• molecular methods
• in silico data analysis
• image analysis
• proteomics

• Biomarkers of Tumor Progression, Prognosis and Therapy in International Journal of Molecular Sciences (19 articles)